Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail

Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail

Submitted by admin on July 17, 2023 - 9:34am
Source: 
Fierce Biotech
News Tags: 
Pardes Biosciences
COVID-19
antivirals
M&A
Headline: 
Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail
snippet: 

Three months after a phase 2 fail for its COVID-19 antiviral sent Pardes Biosciences on the hunt for strategic alternatives, the biotech has been bailed out via an acquisition by its key shareholders.

Do Not Allow Advertisers to Use My Personal information